Literature DB >> 23140242

Renal transporters in drug development.

Kari M Morrissey1, Sophie L Stocker, Matthias B Wittwer, Lu Xu, Kathleen M Giacomini.   

Abstract

The kidney plays a vital role in the body's defense against potentially toxic xenobiotics and metabolic waste products through elimination pathways. In particular, secretory transporters in the proximal tubule are major determinants of the disposition of xenobiotics, including many prescription drugs. In the past decade, considerable progress has been made in understanding the impact of renal transporters on the disposition of many clinically used drugs. In addition, renal transporters have been implicated as sites for numerous clinically important drug-drug interactions. This review begins with a description of renal drug handling and presents relevant equations for the calculation of renal clearance, including filtration and secretory clearance. In addition, data on the localization, expression, substrates, and inhibitors of renal drug transporters are tabulated. The recent US Food and Drug Administration drug-drug interaction draft guidance as it pertains to the study of renal drug transporters is presented. Renal drug elimination in special populations and transporter splicing variants are also described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23140242     DOI: 10.1146/annurev-pharmtox-011112-140317

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  89 in total

1.  The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.

Authors:  Joao N Dos Santos Pereira; Sina Tadjerpisheh; Manar Abu Abed; Ali R Saadatmand; Babette Weksler; Ignacio A Romero; Pierre-Olivier Couraud; Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  AAPS J       Date:  2014-08-26       Impact factor: 4.009

2.  Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).

Authors:  Qing Li; Dong Guo; Zhongqi Dong; Wei Zhang; Lei Zhang; Shiew-Mei Huang; James E Polli; Yan Shu
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-31       Impact factor: 4.219

3.  Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.

Authors:  John K Fallon; Philip C Smith; Cindy Q Xia; Mi-Sook Kim
Journal:  Pharm Res       Date:  2016-06-29       Impact factor: 4.200

4.  Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1).

Authors:  Qing Li; Zhi Ye; Peng Zhu; Dong Guo; Hong Yang; Jin Huang; Wei Zhang; James E Polli; Yan Shu
Journal:  Pharm Res       Date:  2018-01-04       Impact factor: 4.200

Review 5.  Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics.

Authors:  Piyush Bajaj; Swapan K Chowdhury; Robert Yucha; Edward J Kelly; Guangqing Xiao
Journal:  Drug Metab Dispos       Date:  2018-08-03       Impact factor: 3.922

6.  Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.

Authors:  Jia Yin; Haichuan Duan; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-10-06       Impact factor: 4.030

7.  Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Rhiannon N Hardwick; April D Lake; Anika L Dzierlenga; John D Clarke; Michael J Goedken; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2014-12-08       Impact factor: 3.922

8.  Development of a microphysiological model of human kidney proximal tubule function.

Authors:  Elijah J Weber; Alenka Chapron; Brian D Chapron; Jenna L Voellinger; Kevin A Lidberg; Catherine K Yeung; Zhican Wang; Yoshiyuki Yamaura; Dale W Hailey; Thomas Neumann; Danny D Shen; Kenneth E Thummel; Kimberly A Muczynski; Jonathan Himmelfarb; Edward J Kelly
Journal:  Kidney Int       Date:  2016-09       Impact factor: 10.612

9.  Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies.

Authors:  Sook Wah Yee; Dina Buitrago; Adrian Stecula; Huy X Ngo; Huan-Chieh Chien; Ling Zou; Megan L Koleske; Kathleen M Giacomini
Journal:  FASEB J       Date:  2020-10-30       Impact factor: 5.191

10.  Exhaustive exercise decreases renal organic anion transporter 3 function.

Authors:  Tipwadee Bunprajun; Chaowalit Yuajit; Rattikarn Noitem; Varanuj Chatsudthipong
Journal:  J Physiol Sci       Date:  2018-10-03       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.